Interrupting the treatment of vulnerable people on immune-suppressing medicines, doubles their antibody response to COVID-19 booster vaccination Posted: Monday, July 11, 2022 A major clinical trial supported by Manchester BRC researchers has found that by interrupting the treatment of vulnerable people on long-term immune supressing medicines for two weeks after a COVID-19 booster vaccination, their antibody response to the jab is doubled. Continue reading full article: Interrupting the treatment of vulnerable people on immune-suppressing medicines, doubles their antibody response to COVID-19 booster vaccination
Taking charge of arthritis – Dr James Bluett speaks to Arthritis Digest Posted: Friday, May 13, 2022 BRC Musculoskeletal researcher Dr James Bluett talks to Arthritis Digest magazine about how new tests will support patients with rheumatoid arthritis to regain control of their health. Continue reading full article: Taking charge of arthritis – Dr James Bluett speaks to Arthritis Digest
Manchester BRC musculoskeletal researchers publish ‘ground-breaking’ national guidelines for myositis Posted: Wednesday, May 11, 2022 Researchers from Manchester BRC’s Musculoskeletal (MSK) Theme have published the first guidelines on the care and treatment of patients with the rare autoimmune condition, myositis. Continue reading full article: Manchester BRC musculoskeletal researchers publish ‘ground-breaking’ national guidelines for myositis
Myositis and remote patient monitoring – Dr Alexander Oldroyd speaks to Arthritis Digest Posted: Monday, March 14, 2022 Continuing regular contributions from our BRC Musculoskeletal (MSK) theme researchers, Dr Alexander Oldroyd speaks to Arthritis Digest magazine about how technology could potentially help predict flares in patients with the autoimmune condition, myositis. Continue reading full article: Myositis and remote patient monitoring – Dr Alexander Oldroyd speaks to Arthritis Digest
Manchester BRC researchers receive prestigious national appointments Posted: Monday, March 14, 2022 Three researchers from Manchester Biomedical Research Centre (BRC) have been appointed Senior Investigators by the National Institute for Health Research (NIHR). Continue reading full article: Manchester BRC researchers receive prestigious national appointments
UK collaboration sees NIHR IMID BioResource pass major recruitment milestone Posted: Tuesday, February 15, 2022 The NIHR Immune Mediated Inflammatory Disease (IMID) BioResource recently hit a major recruitment milestone of 2000 volunteers, thanks to the collaborative effort of centres across England. Continue reading full article: UK collaboration sees NIHR IMID BioResource pass major recruitment milestone
Study profiles side-effects linked to common immunosuppressant methotrexate Posted: Thursday, January 27, 2022 New research led by University of Manchester and NIHR Manchester Biomedical Research Centre (BRC) scientists has profiled the side effects of methotrexate – a common drug used to treat arthritis and other autoimmune diseases. Continue reading full article: Study profiles side-effects linked to common immunosuppressant methotrexate
From Manchester to Toronto – Improving lupus ‘brain fog’ Posted: Tuesday, January 18, 2022 Author: Dr Michelle Barraclough Dr Michelle Barraclough, Research Associate for Manchester BRC’s Musculoskeletal theme, shares her work on improving 'brain fog' for lupus patients, as part of a year-long research placement in Toronto, Canada. Continue reading full article: From Manchester to Toronto – Improving lupus ‘brain fog’